Home> Industry Information> Ten Chinese Cell Culture Based Rabies Vaccines Suppliers Popular in European and American Countries

Ten Chinese Cell Culture Based Rabies Vaccines Suppliers Popular in European and American Countries

June 15, 2024

Ten Chinese Cell Culture Based Rabies Vaccines Suppliers Popular in European and American Countries
The pharmaceutical industry is facing increasing demand for Cell Culture Based Rabies Vaccines due to concerns over traditional vaccine production methods. Companies are investing in research and development to improve production efficiency and ensure a stable supply of vaccines for global distribution.

Changchun Institute of Biological Products Co., Ltd.

Establishment time : 1947

website : http://www.cibp.com.cn/

Main Product : Vaccines, biological products

Company Profile

Changchun Institute of Biological Products Co., Ltd. is a renowned company established in 1947, specializing in the production of vaccines and biological products. With a large company size and a strong presence in both domestic and international markets, the company has a competitive edge in the industry due to its leading position and robust research and development capabilities. Visit their website for more information: http://www.cibp.com.cn/

Wuhan Institute of Biological Products Co., Ltd.

Establishment time : 1967

website : http://www.whbp.com.cn/

Main Product : Vaccines, biological products

Company Profile

Wuhan Institute of Biological Products Co., Ltd. is a state-owned enterprise specializing in the research, development, and production of vaccines and biological products. With over 50 years of experience in the industry, the company is committed to providing safe and effective healthcare solutions to improve public health.

Chengdu Institute of Biological Products Co., Ltd.

Establishment time : 1958

website : http://www.cibp.com.cn/

Main Product : Vaccines, blood products, and biological products

Company Profile

Chengdu Institute of Biological Products Co., Ltd. is a renowned biopharmaceutical company that specializes in the research, development, and production of vaccines, blood products, and other biological products. Founded in 1958, the company has grown to become a key player in the industry, serving both domestic and international markets with high-quality and innovative products. With a large workforce of over 1000 employees, the company continues to expand its product portfolio and strengthen its competitive position in the market.

Liaoning Chengda Biotechnology Co., Ltd.

Establishment time : 2002

website : www.chengdabio.com

Main Product : Probiotics, enzymes, feed additives

Company Profile

Liaoning Chengda Biotechnology Co., Ltd. is a trusted manufacturer and supplier of probiotics, enzymes, and feed additives. With a focus on research and development, the company has established itself as a leader in the industry, serving customers in both domestic and international markets.

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Establishment time : 2001

website : www.zjtianyuan.com

Main Product : Heparin Sodium, Enoxaparin Sodium, Chondroitin Sulfate, etc.

Company Profile

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a renowned pharmaceutical company specializing in the production of heparin products, chondroitin sulfate, and other pharmaceutical ingredients. With a commitment to quality and innovation, the company has established itself as a trusted supplier in the global pharmaceutical market.

Changchun Zhuoyi Biological Co., Ltd

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Shenzhen Kangtai Biological Products Co., Ltd.

Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992.

website :

Main Product : With a large company size, Kangtai is a major player in the industry.

Company Profile

For more information, visit their website at http://www.kangtai.com.cn/.

The above is the Ten Chinese Cell Culture Based Rabies Vaccines Suppliers Popular in European and American Countries we have listed for you. You can submit the following form to obtain more industry information we provide for you.

You can visit our website or contact us, and we will provide the latest consultation and solutions

Share to:

Send Inquiry

Home> Industry Information> Ten Chinese Cell Culture Based Rabies Vaccines Suppliers Popular in European and American Countries
We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send